Pfizer seeks approval for Lyme disease vaccine despite trial setbacks
Pfizer announced it will request approval from the FDA for a Lyme disease vaccine, despite not meeting statistical goals in clinical trials. Lyme disease, transmitted by ticks, poses serious health risks, necessitating further research and analysis.